nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyproheptadine—HTR6—Alzheimer's disease	0.39	0.773	CbGaD
Cyproheptadine—HTR2A—Donepezil—Alzheimer's disease	0.145	0.556	CbGbCtD
Cyproheptadine—DRD2—Memantine—Alzheimer's disease	0.116	0.444	CbGbCtD
Cyproheptadine—HTR2A—Alzheimer's disease	0.115	0.227	CbGaD
Cyproheptadine—HTR2C—choroid plexus—Alzheimer's disease	0.0112	0.159	CbGeAlD
Cyproheptadine—SLC6A2—locus ceruleus—Alzheimer's disease	0.00576	0.0819	CbGeAlD
Cyproheptadine—HTR2A—choroid plexus—Alzheimer's disease	0.00561	0.0797	CbGeAlD
Cyproheptadine—HTR2A—locus ceruleus—Alzheimer's disease	0.00346	0.0492	CbGeAlD
Cyproheptadine—Epigastric distress—Donepezil—Alzheimer's disease	0.00331	0.0331	CcSEcCtD
Cyproheptadine—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00328	0.0465	CbGeAlD
Cyproheptadine—HTR2A—cerebellar cortex—Alzheimer's disease	0.00282	0.0401	CbGeAlD
Cyproheptadine—HTR1A—telencephalic ventricle—Alzheimer's disease	0.00276	0.0392	CbGeAlD
Cyproheptadine—DRD2—telencephalic ventricle—Alzheimer's disease	0.00249	0.0354	CbGeAlD
Cyproheptadine—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00164	0.0233	CbGeAlD
Cyproheptadine—HTR6—forebrain—Alzheimer's disease	0.00148	0.021	CbGeAlD
Cyproheptadine—Extrasystoles—Memantine—Alzheimer's disease	0.00138	0.0139	CcSEcCtD
Cyproheptadine—HTR6—telencephalon—Alzheimer's disease	0.00136	0.0193	CbGeAlD
Cyproheptadine—Extrasystoles—Rivastigmine—Alzheimer's disease	0.00135	0.0136	CcSEcCtD
Cyproheptadine—Wheezing—Donepezil—Alzheimer's disease	0.00125	0.0125	CcSEcCtD
Cyproheptadine—Urinary retention—Galantamine—Alzheimer's disease	0.00114	0.0114	CcSEcCtD
Cyproheptadine—Euphoric mood—Donepezil—Alzheimer's disease	0.0011	0.011	CcSEcCtD
Cyproheptadine—Haemolytic anaemia—Donepezil—Alzheimer's disease	0.00103	0.0103	CcSEcCtD
Cyproheptadine—Increased appetite—Donepezil—Alzheimer's disease	0.000992	0.00993	CcSEcCtD
Cyproheptadine—Pollakiuria—Galantamine—Alzheimer's disease	0.00096	0.00961	CcSEcCtD
Cyproheptadine—Hepatic failure—Memantine—Alzheimer's disease	0.000941	0.00942	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Galantamine—Alzheimer's disease	0.000908	0.00909	CcSEcCtD
Cyproheptadine—Increased appetite—Memantine—Alzheimer's disease	0.0009	0.00901	CcSEcCtD
Cyproheptadine—Irritability—Donepezil—Alzheimer's disease	0.000889	0.0089	CcSEcCtD
Cyproheptadine—CHRM2—forebrain—Alzheimer's disease	0.000887	0.0126	CbGeAlD
Cyproheptadine—Urinary retention—Donepezil—Alzheimer's disease	0.000886	0.00887	CcSEcCtD
Cyproheptadine—Increased appetite—Rivastigmine—Alzheimer's disease	0.000881	0.00882	CcSEcCtD
Cyproheptadine—HTR2C—forebrain—Alzheimer's disease	0.000855	0.0121	CbGeAlD
Cyproheptadine—Diplopia—Memantine—Alzheimer's disease	0.000846	0.00847	CcSEcCtD
Cyproheptadine—Hepatitis—Galantamine—Alzheimer's disease	0.000832	0.00833	CcSEcCtD
Cyproheptadine—Diplopia—Rivastigmine—Alzheimer's disease	0.000828	0.00829	CcSEcCtD
Cyproheptadine—Hallucination—Galantamine—Alzheimer's disease	0.000827	0.00828	CcSEcCtD
Cyproheptadine—CHRM2—telencephalon—Alzheimer's disease	0.000816	0.0116	CbGeAlD
Cyproheptadine—HTR2A—blood vessel—Alzheimer's disease	0.000813	0.0116	CbGeAlD
Cyproheptadine—CHRM1—forebrain—Alzheimer's disease	0.000808	0.0115	CbGeAlD
Cyproheptadine—Irritability—Memantine—Alzheimer's disease	0.000807	0.00808	CcSEcCtD
Cyproheptadine—Urinary retention—Memantine—Alzheimer's disease	0.000804	0.00805	CcSEcCtD
Cyproheptadine—HTR6—nervous system—Alzheimer's disease	0.000803	0.0114	CbGeAlD
Cyproheptadine—HTR2B—forebrain—Alzheimer's disease	0.000803	0.0114	CbGeAlD
Cyproheptadine—Urinary retention—Rivastigmine—Alzheimer's disease	0.000787	0.00788	CcSEcCtD
Cyproheptadine—HTR2C—telencephalon—Alzheimer's disease	0.000786	0.0112	CbGeAlD
Cyproheptadine—Sweating increased—Donepezil—Alzheimer's disease	0.000784	0.00785	CcSEcCtD
Cyproheptadine—Tinnitus—Galantamine—Alzheimer's disease	0.000775	0.00776	CcSEcCtD
Cyproheptadine—HTR6—central nervous system—Alzheimer's disease	0.000774	0.011	CbGeAlD
Cyproheptadine—Pollakiuria—Donepezil—Alzheimer's disease	0.000744	0.00745	CcSEcCtD
Cyproheptadine—CHRM1—telencephalon—Alzheimer's disease	0.000743	0.0105	CbGeAlD
Cyproheptadine—HTR2B—telencephalon—Alzheimer's disease	0.000739	0.0105	CbGeAlD
Cyproheptadine—Weight increased—Donepezil—Alzheimer's disease	0.000733	0.00734	CcSEcCtD
Cyproheptadine—CHRM3—forebrain—Alzheimer's disease	0.000723	0.0103	CbGeAlD
Cyproheptadine—HTR1A—forebrain—Alzheimer's disease	0.00072	0.0102	CbGeAlD
Cyproheptadine—SLC6A2—forebrain—Alzheimer's disease	0.000714	0.0101	CbGeAlD
Cyproheptadine—Sweating increased—Memantine—Alzheimer's disease	0.000712	0.00713	CcSEcCtD
Cyproheptadine—Tension—Galantamine—Alzheimer's disease	0.00071	0.00711	CcSEcCtD
Cyproheptadine—Nervousness—Galantamine—Alzheimer's disease	0.000703	0.00704	CcSEcCtD
Cyproheptadine—Jaundice—Donepezil—Alzheimer's disease	0.0007	0.00701	CcSEcCtD
Cyproheptadine—Sweating increased—Rivastigmine—Alzheimer's disease	0.000697	0.00698	CcSEcCtD
Cyproheptadine—Vision blurred—Galantamine—Alzheimer's disease	0.000682	0.00683	CcSEcCtD
Cyproheptadine—Tremor—Galantamine—Alzheimer's disease	0.000678	0.00679	CcSEcCtD
Cyproheptadine—Pollakiuria—Memantine—Alzheimer's disease	0.000675	0.00676	CcSEcCtD
Cyproheptadine—Weight increased—Memantine—Alzheimer's disease	0.000665	0.00666	CcSEcCtD
Cyproheptadine—Agitation—Galantamine—Alzheimer's disease	0.000665	0.00666	CcSEcCtD
Cyproheptadine—CHRM3—telencephalon—Alzheimer's disease	0.000665	0.00944	CbGeAlD
Cyproheptadine—HTR1A—telencephalon—Alzheimer's disease	0.000662	0.0094	CbGeAlD
Cyproheptadine—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000661	0.00662	CcSEcCtD
Cyproheptadine—SLC6A2—telencephalon—Alzheimer's disease	0.000656	0.00932	CbGeAlD
Cyproheptadine—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000653	0.00654	CcSEcCtD
Cyproheptadine—Weight increased—Rivastigmine—Alzheimer's disease	0.000651	0.00652	CcSEcCtD
Cyproheptadine—DRD2—forebrain—Alzheimer's disease	0.00065	0.00924	CbGeAlD
Cyproheptadine—Vertigo—Galantamine—Alzheimer's disease	0.00065	0.00651	CcSEcCtD
Cyproheptadine—Syncope—Galantamine—Alzheimer's disease	0.000649	0.0065	CcSEcCtD
Cyproheptadine—Hepatitis—Donepezil—Alzheimer's disease	0.000645	0.00645	CcSEcCtD
Cyproheptadine—Hallucination—Donepezil—Alzheimer's disease	0.000641	0.00642	CcSEcCtD
Cyproheptadine—Palpitations—Galantamine—Alzheimer's disease	0.00064	0.00641	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000639	0.0064	CcSEcCtD
Cyproheptadine—Drowsiness—Rivastigmine—Alzheimer's disease	0.000638	0.00638	CcSEcCtD
Cyproheptadine—Loss of consciousness—Galantamine—Alzheimer's disease	0.000636	0.00637	CcSEcCtD
Cyproheptadine—Convulsion—Galantamine—Alzheimer's disease	0.000627	0.00628	CcSEcCtD
Cyproheptadine—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000625	0.00626	CcSEcCtD
Cyproheptadine—HTR6—brain—Alzheimer's disease	0.000614	0.00872	CbGeAlD
Cyproheptadine—Agranulocytosis—Memantine—Alzheimer's disease	0.000608	0.00609	CcSEcCtD
Cyproheptadine—Tinnitus—Donepezil—Alzheimer's disease	0.000601	0.00602	CcSEcCtD
Cyproheptadine—DRD2—telencephalon—Alzheimer's disease	0.000598	0.0085	CbGeAlD
Cyproheptadine—Confusional state—Galantamine—Alzheimer's disease	0.000596	0.00596	CcSEcCtD
Cyproheptadine—Hepatitis—Memantine—Alzheimer's disease	0.000585	0.00586	CcSEcCtD
Cyproheptadine—Hallucination—Memantine—Alzheimer's disease	0.000582	0.00583	CcSEcCtD
Cyproheptadine—Shock—Galantamine—Alzheimer's disease	0.000581	0.00582	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000579	0.00579	CcSEcCtD
Cyproheptadine—Chills—Donepezil—Alzheimer's disease	0.000578	0.00579	CcSEcCtD
Cyproheptadine—Tachycardia—Galantamine—Alzheimer's disease	0.000577	0.00577	CcSEcCtD
Cyproheptadine—Hepatitis—Rivastigmine—Alzheimer's disease	0.000573	0.00573	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000571	0.00572	CcSEcCtD
Cyproheptadine—Hallucination—Rivastigmine—Alzheimer's disease	0.00057	0.0057	CcSEcCtD
Cyproheptadine—Anorexia—Galantamine—Alzheimer's disease	0.000563	0.00564	CcSEcCtD
Cyproheptadine—Hypotension—Galantamine—Alzheimer's disease	0.000552	0.00553	CcSEcCtD
Cyproheptadine—Tension—Donepezil—Alzheimer's disease	0.000551	0.00551	CcSEcCtD
Cyproheptadine—Tinnitus—Memantine—Alzheimer's disease	0.000546	0.00546	CcSEcCtD
Cyproheptadine—Nervousness—Donepezil—Alzheimer's disease	0.000545	0.00546	CcSEcCtD
Cyproheptadine—Insomnia—Galantamine—Alzheimer's disease	0.000534	0.00535	CcSEcCtD
Cyproheptadine—Tinnitus—Rivastigmine—Alzheimer's disease	0.000534	0.00534	CcSEcCtD
Cyproheptadine—Paraesthesia—Galantamine—Alzheimer's disease	0.000531	0.00531	CcSEcCtD
Cyproheptadine—Vision blurred—Donepezil—Alzheimer's disease	0.000529	0.00529	CcSEcCtD
Cyproheptadine—Tremor—Donepezil—Alzheimer's disease	0.000526	0.00526	CcSEcCtD
Cyproheptadine—Somnolence—Galantamine—Alzheimer's disease	0.000525	0.00526	CcSEcCtD
Cyproheptadine—Chills—Memantine—Alzheimer's disease	0.000525	0.00526	CcSEcCtD
Cyproheptadine—Dyspepsia—Galantamine—Alzheimer's disease	0.00052	0.00521	CcSEcCtD
Cyproheptadine—Agitation—Donepezil—Alzheimer's disease	0.000516	0.00516	CcSEcCtD
Cyproheptadine—HRH1—forebrain—Alzheimer's disease	0.000514	0.0073	CbGeAlD
Cyproheptadine—Chills—Rivastigmine—Alzheimer's disease	0.000514	0.00514	CcSEcCtD
Cyproheptadine—Decreased appetite—Galantamine—Alzheimer's disease	0.000514	0.00514	CcSEcCtD
Cyproheptadine—Fatigue—Galantamine—Alzheimer's disease	0.000509	0.0051	CcSEcCtD
Cyproheptadine—Constipation—Galantamine—Alzheimer's disease	0.000505	0.00506	CcSEcCtD
Cyproheptadine—Vertigo—Donepezil—Alzheimer's disease	0.000504	0.00505	CcSEcCtD
Cyproheptadine—Syncope—Donepezil—Alzheimer's disease	0.000503	0.00504	CcSEcCtD
Cyproheptadine—Tension—Memantine—Alzheimer's disease	0.0005	0.00501	CcSEcCtD
Cyproheptadine—Nervousness—Memantine—Alzheimer's disease	0.000495	0.00495	CcSEcCtD
Cyproheptadine—Loss of consciousness—Donepezil—Alzheimer's disease	0.000493	0.00494	CcSEcCtD
Cyproheptadine—Tension—Rivastigmine—Alzheimer's disease	0.000489	0.0049	CcSEcCtD
Cyproheptadine—Feeling abnormal—Galantamine—Alzheimer's disease	0.000487	0.00487	CcSEcCtD
Cyproheptadine—Convulsion—Donepezil—Alzheimer's disease	0.000486	0.00487	CcSEcCtD
Cyproheptadine—HTR2A—embryo—Alzheimer's disease	0.000485	0.00689	CbGeAlD
Cyproheptadine—Nervousness—Rivastigmine—Alzheimer's disease	0.000484	0.00485	CcSEcCtD
Cyproheptadine—CHRM2—nervous system—Alzheimer's disease	0.000482	0.00684	CbGeAlD
Cyproheptadine—Vision blurred—Memantine—Alzheimer's disease	0.00048	0.00481	CcSEcCtD
Cyproheptadine—Tremor—Memantine—Alzheimer's disease	0.000477	0.00478	CcSEcCtD
Cyproheptadine—HRH1—telencephalon—Alzheimer's disease	0.000472	0.00671	CbGeAlD
Cyproheptadine—Vision blurred—Rivastigmine—Alzheimer's disease	0.00047	0.0047	CcSEcCtD
Cyproheptadine—Agitation—Memantine—Alzheimer's disease	0.000468	0.00469	CcSEcCtD
Cyproheptadine—Tremor—Rivastigmine—Alzheimer's disease	0.000467	0.00467	CcSEcCtD
Cyproheptadine—HTR2C—nervous system—Alzheimer's disease	0.000464	0.00659	CbGeAlD
Cyproheptadine—CHRM2—central nervous system—Alzheimer's disease	0.000464	0.00659	CbGeAlD
Cyproheptadine—Confusional state—Donepezil—Alzheimer's disease	0.000462	0.00462	CcSEcCtD
Cyproheptadine—Agitation—Rivastigmine—Alzheimer's disease	0.000458	0.00459	CcSEcCtD
Cyproheptadine—Oedema—Donepezil—Alzheimer's disease	0.000458	0.00458	CcSEcCtD
Cyproheptadine—Vertigo—Memantine—Alzheimer's disease	0.000458	0.00458	CcSEcCtD
Cyproheptadine—Syncope—Memantine—Alzheimer's disease	0.000457	0.00457	CcSEcCtD
Cyproheptadine—Leukopenia—Memantine—Alzheimer's disease	0.000456	0.00457	CcSEcCtD
Cyproheptadine—Shock—Donepezil—Alzheimer's disease	0.000451	0.00451	CcSEcCtD
Cyproheptadine—Palpitations—Memantine—Alzheimer's disease	0.00045	0.00451	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000448	0.00449	CcSEcCtD
Cyproheptadine—Vertigo—Rivastigmine—Alzheimer's disease	0.000448	0.00448	CcSEcCtD
Cyproheptadine—Loss of consciousness—Memantine—Alzheimer's disease	0.000448	0.00448	CcSEcCtD
Cyproheptadine—HTR2C—central nervous system—Alzheimer's disease	0.000447	0.00635	CbGeAlD
Cyproheptadine—Syncope—Rivastigmine—Alzheimer's disease	0.000447	0.00447	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000443	0.00443	CcSEcCtD
Cyproheptadine—Convulsion—Memantine—Alzheimer's disease	0.000441	0.00442	CcSEcCtD
Cyproheptadine—Palpitations—Rivastigmine—Alzheimer's disease	0.00044	0.00441	CcSEcCtD
Cyproheptadine—Amitriptyline—NTRK2—Alzheimer's disease	0.000439	0.12	CrCbGaD
Cyproheptadine—CHRM1—nervous system—Alzheimer's disease	0.000438	0.00623	CbGeAlD
Cyproheptadine—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000438	0.00439	CcSEcCtD
Cyproheptadine—Anorexia—Donepezil—Alzheimer's disease	0.000436	0.00437	CcSEcCtD
Cyproheptadine—HTR2B—nervous system—Alzheimer's disease	0.000436	0.00619	CbGeAlD
Cyproheptadine—Convulsion—Rivastigmine—Alzheimer's disease	0.000432	0.00432	CcSEcCtD
Cyproheptadine—HTR2A—forebrain—Alzheimer's disease	0.000429	0.00609	CbGeAlD
Cyproheptadine—Hypotension—Donepezil—Alzheimer's disease	0.000428	0.00428	CcSEcCtD
Cyproheptadine—Asthenia—Galantamine—Alzheimer's disease	0.000424	0.00424	CcSEcCtD
Cyproheptadine—CHRM1—central nervous system—Alzheimer's disease	0.000422	0.006	CbGeAlD
Cyproheptadine—HTR2B—central nervous system—Alzheimer's disease	0.00042	0.00596	CbGeAlD
Cyproheptadine—Confusional state—Memantine—Alzheimer's disease	0.000419	0.0042	CcSEcCtD
Cyproheptadine—Oedema—Memantine—Alzheimer's disease	0.000416	0.00416	CcSEcCtD
Cyproheptadine—Insomnia—Donepezil—Alzheimer's disease	0.000414	0.00415	CcSEcCtD
Cyproheptadine—Paraesthesia—Donepezil—Alzheimer's disease	0.000411	0.00412	CcSEcCtD
Cyproheptadine—Confusional state—Rivastigmine—Alzheimer's disease	0.00041	0.00411	CcSEcCtD
Cyproheptadine—Shock—Memantine—Alzheimer's disease	0.000409	0.0041	CcSEcCtD
Cyproheptadine—Somnolence—Donepezil—Alzheimer's disease	0.000407	0.00408	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Memantine—Alzheimer's disease	0.000407	0.00408	CcSEcCtD
Cyproheptadine—Oedema—Rivastigmine—Alzheimer's disease	0.000407	0.00407	CcSEcCtD
Cyproheptadine—Tachycardia—Memantine—Alzheimer's disease	0.000406	0.00406	CcSEcCtD
Cyproheptadine—Diarrhoea—Galantamine—Alzheimer's disease	0.000404	0.00405	CcSEcCtD
Cyproheptadine—Dyspepsia—Donepezil—Alzheimer's disease	0.000403	0.00404	CcSEcCtD
Cyproheptadine—Hyperhidrosis—Memantine—Alzheimer's disease	0.000402	0.00402	CcSEcCtD
Cyproheptadine—Shock—Rivastigmine—Alzheimer's disease	0.0004	0.00401	CcSEcCtD
Cyproheptadine—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000398	0.00399	CcSEcCtD
Cyproheptadine—Decreased appetite—Donepezil—Alzheimer's disease	0.000398	0.00399	CcSEcCtD
Cyproheptadine—Tachycardia—Rivastigmine—Alzheimer's disease	0.000397	0.00397	CcSEcCtD
Cyproheptadine—Anorexia—Memantine—Alzheimer's disease	0.000396	0.00397	CcSEcCtD
Cyproheptadine—Fatigue—Donepezil—Alzheimer's disease	0.000395	0.00395	CcSEcCtD
Cyproheptadine—HTR2A—telencephalon—Alzheimer's disease	0.000395	0.0056	CbGeAlD
Cyproheptadine—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.000393	0.00394	CcSEcCtD
Cyproheptadine—CHRM3—nervous system—Alzheimer's disease	0.000392	0.00557	CbGeAlD
Cyproheptadine—Constipation—Donepezil—Alzheimer's disease	0.000392	0.00392	CcSEcCtD
Cyproheptadine—HTR1A—nervous system—Alzheimer's disease	0.000391	0.00555	CbGeAlD
Cyproheptadine—Dizziness—Galantamine—Alzheimer's disease	0.000391	0.00391	CcSEcCtD
Cyproheptadine—Hypotension—Memantine—Alzheimer's disease	0.000389	0.00389	CcSEcCtD
Cyproheptadine—Anorexia—Rivastigmine—Alzheimer's disease	0.000388	0.00388	CcSEcCtD
Cyproheptadine—SLC6A2—nervous system—Alzheimer's disease	0.000388	0.0055	CbGeAlD
Cyproheptadine—Hypotension—Rivastigmine—Alzheimer's disease	0.00038	0.00381	CcSEcCtD
Cyproheptadine—CHRM3—central nervous system—Alzheimer's disease	0.000378	0.00537	CbGeAlD
Cyproheptadine—Feeling abnormal—Donepezil—Alzheimer's disease	0.000377	0.00378	CcSEcCtD
Cyproheptadine—HTR1A—central nervous system—Alzheimer's disease	0.000376	0.00534	CbGeAlD
Cyproheptadine—Insomnia—Memantine—Alzheimer's disease	0.000376	0.00376	CcSEcCtD
Cyproheptadine—Vomiting—Galantamine—Alzheimer's disease	0.000376	0.00376	CcSEcCtD
Cyproheptadine—Paraesthesia—Memantine—Alzheimer's disease	0.000373	0.00374	CcSEcCtD
Cyproheptadine—SLC6A2—central nervous system—Alzheimer's disease	0.000373	0.0053	CbGeAlD
Cyproheptadine—Rash—Galantamine—Alzheimer's disease	0.000373	0.00373	CcSEcCtD
Cyproheptadine—Dermatitis—Galantamine—Alzheimer's disease	0.000372	0.00373	CcSEcCtD
Cyproheptadine—Headache—Galantamine—Alzheimer's disease	0.00037	0.00371	CcSEcCtD
Cyproheptadine—Somnolence—Memantine—Alzheimer's disease	0.00037	0.0037	CcSEcCtD
Cyproheptadine—CHRM2—brain—Alzheimer's disease	0.000368	0.00523	CbGeAlD
Cyproheptadine—Insomnia—Rivastigmine—Alzheimer's disease	0.000368	0.00368	CcSEcCtD
Cyproheptadine—HTR1A—cerebellum—Alzheimer's disease	0.000368	0.00522	CbGeAlD
Cyproheptadine—Dyspepsia—Memantine—Alzheimer's disease	0.000366	0.00366	CcSEcCtD
Cyproheptadine—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000365	0.00366	CcSEcCtD
Cyproheptadine—Urticaria—Donepezil—Alzheimer's disease	0.000364	0.00364	CcSEcCtD
Cyproheptadine—Somnolence—Rivastigmine—Alzheimer's disease	0.000362	0.00362	CcSEcCtD
Cyproheptadine—Decreased appetite—Memantine—Alzheimer's disease	0.000361	0.00362	CcSEcCtD
Cyproheptadine—Fatigue—Memantine—Alzheimer's disease	0.000358	0.00359	CcSEcCtD
Cyproheptadine—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000358	0.00358	CcSEcCtD
Cyproheptadine—Constipation—Memantine—Alzheimer's disease	0.000356	0.00356	CcSEcCtD
Cyproheptadine—HTR2C—brain—Alzheimer's disease	0.000355	0.00504	CbGeAlD
Cyproheptadine—Decreased appetite—Rivastigmine—Alzheimer's disease	0.000354	0.00354	CcSEcCtD
Cyproheptadine—DRD2—nervous system—Alzheimer's disease	0.000353	0.00502	CbGeAlD
Cyproheptadine—Nausea—Galantamine—Alzheimer's disease	0.000351	0.00351	CcSEcCtD
Cyproheptadine—Fatigue—Rivastigmine—Alzheimer's disease	0.000351	0.00351	CcSEcCtD
Cyproheptadine—Constipation—Rivastigmine—Alzheimer's disease	0.000348	0.00348	CcSEcCtD
Cyproheptadine—Feeling abnormal—Memantine—Alzheimer's disease	0.000343	0.00343	CcSEcCtD
Cyproheptadine—DRD2—central nervous system—Alzheimer's disease	0.00034	0.00483	CbGeAlD
Cyproheptadine—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000335	0.00336	CcSEcCtD
Cyproheptadine—CHRM1—brain—Alzheimer's disease	0.000335	0.00476	CbGeAlD
Cyproheptadine—HTR2B—brain—Alzheimer's disease	0.000333	0.00474	CbGeAlD
Cyproheptadine—DRD2—cerebellum—Alzheimer's disease	0.000332	0.00472	CbGeAlD
Cyproheptadine—Urticaria—Memantine—Alzheimer's disease	0.00033	0.00331	CcSEcCtD
Cyproheptadine—Asthenia—Donepezil—Alzheimer's disease	0.000329	0.00329	CcSEcCtD
Cyproheptadine—Urticaria—Rivastigmine—Alzheimer's disease	0.000323	0.00324	CcSEcCtD
Cyproheptadine—Mianserin—HTR6—Alzheimer's disease	0.000319	0.087	CrCbGaD
Cyproheptadine—Diarrhoea—Donepezil—Alzheimer's disease	0.000313	0.00314	CcSEcCtD
Cyproheptadine—Dizziness—Donepezil—Alzheimer's disease	0.000303	0.00303	CcSEcCtD
Cyproheptadine—CHRM3—brain—Alzheimer's disease	0.0003	0.00426	CbGeAlD
Cyproheptadine—HTR1A—brain—Alzheimer's disease	0.000299	0.00424	CbGeAlD
Cyproheptadine—Asthenia—Memantine—Alzheimer's disease	0.000298	0.00299	CcSEcCtD
Cyproheptadine—SLC6A2—brain—Alzheimer's disease	0.000296	0.00421	CbGeAlD
Cyproheptadine—Asthenia—Rivastigmine—Alzheimer's disease	0.000292	0.00292	CcSEcCtD
Cyproheptadine—Vomiting—Donepezil—Alzheimer's disease	0.000291	0.00291	CcSEcCtD
Cyproheptadine—Rash—Donepezil—Alzheimer's disease	0.000289	0.00289	CcSEcCtD
Cyproheptadine—Dermatitis—Donepezil—Alzheimer's disease	0.000288	0.00289	CcSEcCtD
Cyproheptadine—Headache—Donepezil—Alzheimer's disease	0.000287	0.00287	CcSEcCtD
Cyproheptadine—Nortriptyline—HTR6—Alzheimer's disease	0.000285	0.0777	CrCbGaD
Cyproheptadine—Protriptyline—SLC6A4—Alzheimer's disease	0.000285	0.0777	CrCbGaD
Cyproheptadine—Diarrhoea—Memantine—Alzheimer's disease	0.000284	0.00285	CcSEcCtD
Cyproheptadine—HRH1—nervous system—Alzheimer's disease	0.000279	0.00396	CbGeAlD
Cyproheptadine—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000278	0.00279	CcSEcCtD
Cyproheptadine—Dizziness—Memantine—Alzheimer's disease	0.000275	0.00275	CcSEcCtD
Cyproheptadine—Nausea—Donepezil—Alzheimer's disease	0.000272	0.00272	CcSEcCtD
Cyproheptadine—DRD2—brain—Alzheimer's disease	0.00027	0.00383	CbGeAlD
Cyproheptadine—Dizziness—Rivastigmine—Alzheimer's disease	0.000269	0.00269	CcSEcCtD
Cyproheptadine—HRH1—central nervous system—Alzheimer's disease	0.000268	0.00381	CbGeAlD
Cyproheptadine—Vomiting—Memantine—Alzheimer's disease	0.000264	0.00265	CcSEcCtD
Cyproheptadine—Rash—Memantine—Alzheimer's disease	0.000262	0.00262	CcSEcCtD
Cyproheptadine—Dermatitis—Memantine—Alzheimer's disease	0.000262	0.00262	CcSEcCtD
Cyproheptadine—Headache—Memantine—Alzheimer's disease	0.00026	0.00261	CcSEcCtD
Cyproheptadine—Vomiting—Rivastigmine—Alzheimer's disease	0.000259	0.00259	CcSEcCtD
Cyproheptadine—Rash—Rivastigmine—Alzheimer's disease	0.000256	0.00257	CcSEcCtD
Cyproheptadine—Dermatitis—Rivastigmine—Alzheimer's disease	0.000256	0.00257	CcSEcCtD
Cyproheptadine—Headache—Rivastigmine—Alzheimer's disease	0.000255	0.00255	CcSEcCtD
Cyproheptadine—Loxapine—HTR6—Alzheimer's disease	0.000253	0.0691	CrCbGaD
Cyproheptadine—Nausea—Memantine—Alzheimer's disease	0.000247	0.00247	CcSEcCtD
Cyproheptadine—Nausea—Rivastigmine—Alzheimer's disease	0.000242	0.00242	CcSEcCtD
Cyproheptadine—HTR2A—nervous system—Alzheimer's disease	0.000233	0.00331	CbGeAlD
Cyproheptadine—HTR2A—central nervous system—Alzheimer's disease	0.000224	0.00318	CbGeAlD
Cyproheptadine—HTR2A—cerebellum—Alzheimer's disease	0.000219	0.00311	CbGeAlD
Cyproheptadine—HRH1—brain—Alzheimer's disease	0.000213	0.00303	CbGeAlD
Cyproheptadine—Clozapine—HTR6—Alzheimer's disease	0.000213	0.058	CrCbGaD
Cyproheptadine—Protriptyline—CYP2D6—Alzheimer's disease	0.0002	0.0546	CrCbGaD
Cyproheptadine—Amitriptyline—HTR6—Alzheimer's disease	0.000198	0.0539	CrCbGaD
Cyproheptadine—HTR2A—brain—Alzheimer's disease	0.000178	0.00253	CbGeAlD
Cyproheptadine—Cyclobenzaprine—HTR2A—Alzheimer's disease	0.000163	0.0446	CrCbGaD
Cyproheptadine—Cyclobenzaprine—CYP2D6—Alzheimer's disease	0.000149	0.0407	CrCbGaD
Cyproheptadine—Mianserin—SLC6A4—Alzheimer's disease	0.000122	0.0333	CrCbGaD
Cyproheptadine—Nortriptyline—PTGS1—Alzheimer's disease	0.000113	0.0307	CrCbGaD
Cyproheptadine—Nortriptyline—SLC6A4—Alzheimer's disease	0.000109	0.0298	CrCbGaD
Cyproheptadine—Loxapine—SLC6A4—Alzheimer's disease	9.7e-05	0.0265	CrCbGaD
Cyproheptadine—Mianserin—HTR2A—Alzheimer's disease	9.38e-05	0.0256	CrCbGaD
Cyproheptadine—Mianserin—CYP2D6—Alzheimer's disease	8.58e-05	0.0234	CrCbGaD
Cyproheptadine—Nortriptyline—HTR2A—Alzheimer's disease	8.38e-05	0.0229	CrCbGaD
Cyproheptadine—Nortriptyline—CYP2D6—Alzheimer's disease	7.67e-05	0.0209	CrCbGaD
Cyproheptadine—Amitriptyline—SLC6A4—Alzheimer's disease	7.57e-05	0.0207	CrCbGaD
Cyproheptadine—Loxapine—HTR2A—Alzheimer's disease	7.45e-05	0.0203	CrCbGaD
Cyproheptadine—Clozapine—HTR2A—Alzheimer's disease	6.26e-05	0.0171	CrCbGaD
Cyproheptadine—Amitriptyline—HTR2A—Alzheimer's disease	5.82e-05	0.0159	CrCbGaD
Cyproheptadine—Clozapine—CYP2D6—Alzheimer's disease	5.72e-05	0.0156	CrCbGaD
Cyproheptadine—Amitriptyline—CYP2D6—Alzheimer's disease	5.32e-05	0.0145	CrCbGaD
Cyproheptadine—HTR2B—Signaling Pathways—CCL2—Alzheimer's disease	5.93e-06	9.94e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LPL—Alzheimer's disease	5.89e-06	9.89e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LPL—Alzheimer's disease	5.88e-06	9.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CALM1—Alzheimer's disease	5.88e-06	9.86e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LPL—Alzheimer's disease	5.86e-06	9.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—APOE—Alzheimer's disease	5.86e-06	9.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LPL—Alzheimer's disease	5.84e-06	9.8e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MEF2C—Alzheimer's disease	5.84e-06	9.8e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MEF2C—Alzheimer's disease	5.83e-06	9.78e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IGF1—Alzheimer's disease	5.83e-06	9.78e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—PRKCG—Alzheimer's disease	5.82e-06	9.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MEF2C—Alzheimer's disease	5.81e-06	9.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—CAV1—Alzheimer's disease	5.8e-06	9.74e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MEF2C—Alzheimer's disease	5.79e-06	9.72e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—NOS3—Alzheimer's disease	5.79e-06	9.71e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LPL—Alzheimer's disease	5.79e-06	9.71e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CALM1—Alzheimer's disease	5.74e-06	9.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MEF2C—Alzheimer's disease	5.73e-06	9.62e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—PRKCG—Alzheimer's disease	5.73e-06	9.61e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—APOE—Alzheimer's disease	5.72e-06	9.59e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—LEP—Alzheimer's disease	5.72e-06	9.59e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—PRKCG—Alzheimer's disease	5.72e-06	9.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CALM1—Alzheimer's disease	5.71e-06	9.58e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—PRKCG—Alzheimer's disease	5.7e-06	9.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—LEP—Alzheimer's disease	5.69e-06	9.54e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—APOE—Alzheimer's disease	5.69e-06	9.54e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—PRKCG—Alzheimer's disease	5.68e-06	9.53e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NGF—Alzheimer's disease	5.67e-06	9.52e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CAV1—Alzheimer's disease	5.66e-06	9.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CAV1—Alzheimer's disease	5.64e-06	9.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—PRKCG—Alzheimer's disease	5.62e-06	9.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NGF—Alzheimer's disease	5.58e-06	9.37e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NGF—Alzheimer's disease	5.57e-06	9.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NGF—Alzheimer's disease	5.55e-06	9.32e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NGF—Alzheimer's disease	5.53e-06	9.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCR5—Alzheimer's disease	5.52e-06	9.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	5.48e-06	9.2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—ESR1—Alzheimer's disease	5.46e-06	9.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	5.43e-06	9.11e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	5.43e-06	9.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	5.42e-06	9.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	5.4e-06	9.06e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	5.4e-06	9.06e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—F2—Alzheimer's disease	5.39e-06	9.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	5.38e-06	9.03e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—F2—Alzheimer's disease	5.36e-06	9e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	5.33e-06	8.95e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	5.3e-06	8.9e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	5.28e-06	8.87e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—NOS3—Alzheimer's disease	5.28e-06	8.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOTCH1—Alzheimer's disease	5.28e-06	8.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	5.27e-06	8.84e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	5.25e-06	8.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	5.22e-06	8.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PPARG—Alzheimer's disease	5.1e-06	8.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	5.04e-06	8.45e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—LEP—Alzheimer's disease	5.02e-06	8.42e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—APOE—Alzheimer's disease	5.02e-06	8.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—INS—Alzheimer's disease	5e-06	8.4e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	4.97e-06	8.35e-05	CbGpPWpGaD
Cyproheptadine—HTR6—GPCR downstream signaling—AKT1—Alzheimer's disease	4.96e-06	8.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	4.96e-06	8.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—GSK3B—Alzheimer's disease	4.95e-06	8.31e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.95e-06	8.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	4.94e-06	8.29e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	4.94e-06	8.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	4.93e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.93e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.93e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.93e-06	8.27e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	4.91e-06	8.25e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	4.91e-06	8.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	4.91e-06	8.24e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—CASP3—Alzheimer's disease	4.91e-06	8.24e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CREB1—Alzheimer's disease	4.91e-06	8.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	4.9e-06	8.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	4.9e-06	8.22e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	4.89e-06	8.21e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.89e-06	8.2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—INS—Alzheimer's disease	4.88e-06	8.2e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.88e-06	8.19e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—IL6—Alzheimer's disease	4.88e-06	8.19e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	4.87e-06	8.17e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	4.87e-06	8.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.86e-06	8.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	4.85e-06	8.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	4.85e-06	8.14e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	4.85e-06	8.14e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CCL2—Alzheimer's disease	4.81e-06	8.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	4.8e-06	8.06e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	4.79e-06	8.04e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.78e-06	8.02e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—F2—Alzheimer's disease	4.73e-06	7.94e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IGF1—Alzheimer's disease	4.72e-06	7.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	4.72e-06	7.91e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.71e-06	7.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.7e-06	7.89e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	4.69e-06	7.87e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	4.68e-06	7.85e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—F2—Alzheimer's disease	4.66e-06	7.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.65e-06	7.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—F2—Alzheimer's disease	4.63e-06	7.77e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.63e-06	7.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	4.63e-06	7.77e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—F2—Alzheimer's disease	4.62e-06	7.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—F2—Alzheimer's disease	4.57e-06	7.67e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.56e-06	7.65e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.55e-06	7.63e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.53e-06	7.61e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—GPCR downstream signaling—AKT1—Alzheimer's disease	4.53e-06	7.6e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	4.52e-06	7.58e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—MAPK8—Alzheimer's disease	4.51e-06	7.58e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling by GPCR—AKT1—Alzheimer's disease	4.5e-06	7.56e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—CASP3—Alzheimer's disease	4.48e-06	7.52e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.48e-06	7.51e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—IL6—Alzheimer's disease	4.45e-06	7.48e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—NOS3—Alzheimer's disease	4.39e-06	7.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	4.35e-06	7.3e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	4.31e-06	7.24e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—INS—Alzheimer's disease	4.29e-06	7.2e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—NOS3—Alzheimer's disease	4.28e-06	7.19e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	4.28e-06	7.18e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	4.27e-06	7.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	4.26e-06	7.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	4.25e-06	7.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	4.24e-06	7.12e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	4.24e-06	7.12e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	4.23e-06	7.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	4.22e-06	7.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—INS—Alzheimer's disease	4.22e-06	7.08e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	4.22e-06	7.08e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—INS—Alzheimer's disease	4.21e-06	7.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	4.21e-06	7.06e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	4.2e-06	7.05e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—INS—Alzheimer's disease	4.2e-06	7.04e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—INS—Alzheimer's disease	4.18e-06	7.02e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—VEGFA—Alzheimer's disease	4.17e-06	7e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	4.17e-06	6.99e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	4.15e-06	6.97e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	4.15e-06	6.96e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—INS—Alzheimer's disease	4.14e-06	6.95e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	4.14e-06	6.95e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	4.13e-06	6.93e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—MAPK8—Alzheimer's disease	4.12e-06	6.92e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	4.12e-06	6.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling by GPCR—AKT1—Alzheimer's disease	4.11e-06	6.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	4.08e-06	6.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	4.08e-06	6.84e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	4.07e-06	6.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	4.06e-06	6.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	4.05e-06	6.79e-05	CbGpPWpGaD
Cyproheptadine—UGT1A3—Metabolism—AKT1—Alzheimer's disease	4.04e-06	6.78e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—PTGS2—Alzheimer's disease	4.01e-06	6.73e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	4.01e-06	6.72e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TGFB1—Alzheimer's disease	3.83e-06	6.42e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—VEGFA—Alzheimer's disease	3.8e-06	6.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.76e-06	6.31e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.7e-06	6.21e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.69e-06	6.2e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.68e-06	6.18e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.67e-06	6.16e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	3.67e-06	6.16e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.65e-06	6.13e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—CASP3—Alzheimer's disease	3.64e-06	6.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.63e-06	6.1e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.62e-06	6.07e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—IL6—Alzheimer's disease	3.61e-06	6.06e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.59e-06	6.03e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TGFB1—Alzheimer's disease	3.49e-06	5.86e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—MAPK8—Alzheimer's disease	3.34e-06	5.61e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling by GPCR—AKT1—Alzheimer's disease	3.33e-06	5.59e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.32e-06	5.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.32e-06	5.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.22e-06	5.41e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	3.19e-06	5.36e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	3.17e-06	5.32e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	3.17e-06	5.32e-05	CbGpPWpGaD
Cyproheptadine—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.16e-06	5.31e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	3.15e-06	5.29e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—TP53—Alzheimer's disease	3.15e-06	5.29e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	3.14e-06	5.28e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	3.14e-06	5.27e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	3.13e-06	5.26e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	3.12e-06	5.24e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	3.12e-06	5.24e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	3.11e-06	5.23e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	3.11e-06	5.23e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.11e-06	5.22e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	3.1e-06	5.21e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	3.09e-06	5.19e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—VEGFA—Alzheimer's disease	3.09e-06	5.18e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	3.08e-06	5.18e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	3.07e-06	5.15e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	3.06e-06	5.14e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.93e-06	4.92e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.93e-06	4.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.89e-06	4.85e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—IL6—Alzheimer's disease	2.88e-06	4.84e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.88e-06	4.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.88e-06	4.83e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—TP53—Alzheimer's disease	2.87e-06	4.82e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.87e-06	4.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.87e-06	4.82e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.86e-06	4.81e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	2.86e-06	4.8e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	2.85e-06	4.79e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.83e-06	4.76e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TGFB1—Alzheimer's disease	2.83e-06	4.75e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.83e-06	4.74e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.82e-06	4.73e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.71e-06	4.55e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.67e-06	4.47e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.66e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—HTR6—Signaling Pathways—AKT1—Alzheimer's disease	2.66e-06	4.46e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.65e-06	4.45e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	2.64e-06	4.44e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—IL6—Alzheimer's disease	2.63e-06	4.42e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.62e-06	4.39e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.49e-06	4.17e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.45e-06	4.11e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.44e-06	4.1e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.43e-06	4.08e-05	CbGpPWpGaD
Cyproheptadine—HTR2B—Signaling Pathways—AKT1—Alzheimer's disease	2.43e-06	4.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	2.43e-06	4.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.4e-06	4.03e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—TP53—Alzheimer's disease	2.33e-06	3.91e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.32e-06	3.89e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—IL6—Alzheimer's disease	2.13e-06	3.58e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	2.12e-06	3.56e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—TP53—Alzheimer's disease	2.05e-06	3.44e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Metabolism—AKT1—Alzheimer's disease	2.02e-06	3.38e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	2.01e-06	3.38e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—TP53—Alzheimer's disease	2.01e-06	3.37e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	2e-06	3.36e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	2e-06	3.35e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.98e-06	3.32e-05	CbGpPWpGaD
Cyproheptadine—HTR1A—Signaling Pathways—AKT1—Alzheimer's disease	1.97e-06	3.3e-05	CbGpPWpGaD
Cyproheptadine—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.96e-06	3.29e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.87e-06	3.14e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.84e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.84e-06	3.09e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.83e-06	3.08e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.83e-06	3.07e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.81e-06	3.04e-05	CbGpPWpGaD
Cyproheptadine—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.73e-06	2.9e-05	CbGpPWpGaD
Cyproheptadine—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.7e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.7e-06	2.85e-05	CbGpPWpGaD
Cyproheptadine—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	2.84e-05	CbGpPWpGaD
Cyproheptadine—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.69e-06	2.83e-05	CbGpPWpGaD
Cyproheptadine—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.67e-06	2.8e-05	CbGpPWpGaD
